Kim KH, Yoon S, Ahn HK, Lee SY, et al. A Multicenter Two-arm, Phase II Trial Assessing the Safety and Efficacy of First-line Lazertinib and Locally Ablative Radiotherapy in Patients With Synchronous Oligo-metastatic EGFR-mutant Non-small Cell Lung Cancer (ABLATE, KCSG-LU21-11). Clin Lung Cancer 2022 Aug 7. pii: S1525-7304(22)00169.
PMID: 36002368